(Stroke. 1999;30:2174-2179.)
© 1999 American Heart Association, Inc.
Original Contributions |
Increased IL-1ß, IL-8, and IL-17 mRNA Expression in Blood Mononuclear Cells Observed in a Prospective Ischemic Stroke Study
From the Neuro-Angiological Research Center, Division of Neurology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.
Correspondence to Nikolaos Kostulas, Department of Neurology, Huddinge University Hospital, S-141 86 Huddinge, Sweden. E-mail Nikolakis{at}hotmail.com
Background and
Purpose—Ischemic brain injury secondary to
arterial occlusion is characterized by acute local
inflammation, which involves accumulation of polymorphonuclear
neutrophils (PMN). Factors that influence the recruitment of PMN could
represent new therapeutic targets in acute stroke. In this
prospective study we evaluated numbers of peripheral blood
mononuclear cells (PBMC) expressing mRNA for interleukin (IL)-1ß,
IL-8, and IL-17 and macrophage inflammatory protein-1
(MIP-1) after ischemic stroke.
Methods—Peripheral blood was obtained on days 1 to 3, 4 to 10, and 20 to 31 after onset of symptoms. In situ hybridization with radiolabeled synthetic oligonucleotide probes was adopted to measure cytokine mRNA expression in PBMC. Plasma and cerebrospinal fluid levels of IL-8 were measured by an enzyme-linked immunosorbent assay.
Results—Most patients with ischemic stroke had clearly
elevated numbers of IL-1ß, IL-8, and IL-17 mRNA expressing PBMC 1 to
3 days after onset of symptoms compared with healthy individuals
(P<0.0001 for all comparisons). At follow-up after 20
to 31 days, numbers of IL-8 mRNA expressing PBMC were lower than during
the acute stage (P<0.001), but only IL-1ß and IL-17
mRNA expression had returned to the level of the healthy individuals.
Numbers of MIP-1 mRNA expressing PBMC did not differ between
patients with ischemic stroke and healthy individuals at any
time point. A correlation was observed between numbers of IL-1ß,
IL-8, and IL-17 mRNA expressing PBMC and the degree of neurological
impairment as measured by the Scandinavian Stroke Scale 1 to 3 days
after onset of symptoms (r=0.5;
P<0.01 for all correlations).
Conclusions—A longitudinal study of patients with ischemic stroke revealed systemic increases of levels of IL-1ß, IL-8, and IL-17 that correlated with Scandinavian Stroke Scale scores. IL-8 levels were further increased in cerebrospinal fluid.
Key Words: chemokines • cytokines • inflammation • stroke, ischemic
This article has been cited by other articles:
 |
|
 |
|
  S. Terao, G. Yilmaz, K. Y. Stokes, J. Russell, M. Ishikawa, T. Kawase, and D. N. Granger Blood Cell-Derived RANTES Mediates Cerebral Microvascular Dysfunction, Inflammation, and Tissue Injury After Focal Ischemia-Reperfusion Stroke, September 1, 2008; 39(9): 2560 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C J S Price, E A Warburton, and D K Menon Human cellular inflammation in the pathology of acute cerebral ischaemia J. Neurol. Neurosurg. Psychiatry, November 1, 2003; 74(11): 1476 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Murphy, K. R. Bruckdorfer, D. C. Grimsditch, P. Overend, M. Vidgeon-Hart, P. H.E. Groot, G. M. Benson, and A. Graham Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1615 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Tarnacka, G. Gromadzka, and A. Czlonkowska Increased Circulating Immune Complexes in Acute Stroke: The Triggering Role of Chlamydia pneumoniae and Cytomegalovirus Stroke, April 1, 2002; 33(4): 936 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shi, S. J. Ullrich, J. Zhang, K. Connolly, K. J. Grzegorzewski, M. C. Barber, W. Wang, K. Wathen, V. Hodge, C. L. Fisher, et al. A Novel Cytokine Receptor-Ligand Pair. IDENTIFICATION, MOLECULAR CHARACTERIZATION, AND IN VIVO IMMUNOMODULATORY ACTIVITY J. Biol. Chem., June 16, 2000; 275(25): 19167 - 19176. [Abstract] [Full Text] [PDF]
|
|